These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29525516)

  • 21. [Rational anti-epileptic polytherapy. Drug interactions and choice of treatment].
    Salas-Puig J
    Rev Neurol; 2000 May 1-15; 30(9):886-9. PubMed ID: 10870205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy of epilepsy: state of the art and developments.
    Deckers CL; Hekster YA; Keyser A; Meinardi H; Renier WO
    J Clin Pharm Ther; 1997; 22(5-6):309-22. PubMed ID: 19160714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of verapamil as an adjunctive treatment in children with drug-resistant epilepsy: a pilot study.
    Nicita F; Spalice A; Papetti L; Nikanorova M; Iannetti P; Parisi P
    Seizure; 2014 Jan; 23(1):36-40. PubMed ID: 24113539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resective epilepsy surgery for drug-resistant focal epilepsy: a review.
    Jobst BC; Cascino GD
    JAMA; 2015 Jan; 313(3):285-93. PubMed ID: 25602999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modern management of epilepsy: Rational polytherapy.
    Schmidt D
    Baillieres Clin Neurol; 1996 Dec; 5(4):757-63. PubMed ID: 9068879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rational polypharmacy.
    Ferrendelli JA
    Epilepsia; 1995; 36 Suppl 2():S115-8. PubMed ID: 8784220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic strategies in the choice of antiepileptic drugs.
    de Borchgrave V; Delvaux V; de Tourchaninoff M; Dubru JM; Ghariani S; Grisar T; Legros B; Ossemann M; Sadzot B; Tugendhaft P; Van Bogaert P; van Rijckevorsel K;
    Acta Neurol Belg; 2002 Mar; 102(1):6-10. PubMed ID: 12094563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of antiepileptic drugs--principles and practice.
    Sander JW
    Epilepsia; 2004; 45 Suppl 6():28-34. PubMed ID: 15315513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of epilepsy in drug-resistant patients.
    Smith BJ; Cole AJ
    CNS Spectr; 2010 Jan; 15(1 Suppl 2):1, 3-7; quiz 7-8. PubMed ID: 20394187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiopathic epilepsy in dogs: owners' perspectives on management with phenobarbitone and/or potassium bromide.
    Chang Y; Mellor DJ; Anderson TJ
    J Small Anim Pract; 2006 Oct; 47(10):574-81. PubMed ID: 17004949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epilepsy in TSC: certain etiology does not mean certain prognosis.
    Vignoli A; La Briola F; Turner K; Scornavacca G; Chiesa V; Zambrelli E; Piazzini A; Savini MN; Alfano RM; Canevini MP
    Epilepsia; 2013 Dec; 54(12):2134-42. PubMed ID: 24304436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Theoretical and practical considerations in rational polytherapy for epilepsy].
    Rajna P
    Ideggyogy Sz; 2011 Nov; 64(11-12):367-76. PubMed ID: 22611614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiepileptic drug treatment in children.
    Hadjiloizou SM; Bourgeois BF
    Expert Rev Neurother; 2007 Feb; 7(2):179-93. PubMed ID: 17286551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
    Lutz MT; Helmstaedter C
    Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of psychiatric and neurological comorbidities in epilepsy.
    Kanner AM
    Nat Rev Neurol; 2016 Feb; 12(2):106-16. PubMed ID: 26782334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety evaluation of loreclezole as add-on treatment in therapy-resistant epilepsy patients.
    Rentmeester T; Hulsman J
    Epilepsy Res; 1991 Mar; 8(2):166-9. PubMed ID: 2065645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The challenges of treating epilepsy with 25 antiepileptic drugs.
    Santulli L; Coppola A; Balestrini S; Striano S
    Pharmacol Res; 2016 May; 107():211-219. PubMed ID: 26995307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The new antiepileptic drugs: their indications and side effects].
    Malagón-Valdez J
    Rev Neurol; 2004 Sep 16-30; 39(6):570-5. PubMed ID: 15467997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies.
    Pati S; Alexopoulos AV
    Cleve Clin J Med; 2010 Jul; 77(7):457-67. PubMed ID: 20601619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug-resistant epilepsy].
    Nakken KO; Taubøll E
    Tidsskr Nor Laegeforen; 2009 Oct; 129(19):1986-9. PubMed ID: 19823202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.